ArticleBone reports2026
Collagen secretion and maturation in osteogenesis imperfecta: Systematic review and meta-analysis.
Article in Bone reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteogenesis imperfecta (OI) is a rare genetic disorder most often caused by mutation in genes that encode collagen type I. The collagen pathway is a complex process involving collagen folding, secretion and fibril assembly. The underlying mutation of OI causes a cascade effect resulting alterations at all levels of the collagen pathway. The objective of this study is to use knowledge synthesis to quantify the collagen-I folding kinetics, secretion kinetics, crosslinks, fibril diameter and melting temperature. A systematic search in Medline, Ovid and Web of Science, identified 1001 studies reporting on selected outcomes in OI patients. After screening, we included 51 qualitative studies, 8 quantitative and 43 studies for meta-analysis. Meta-analysis of studies with quantitative data was performed using normalized mean difference as a study-level effect size and a random-effects model with the Hunter and Smith with sample size correction. The collagen-I folding half-life dataset included 8 patients across 3 studies and had an effect size of 0.88 (confidence interval (CI) 0.31, 1.46). The collagen secretion half-life dataset included 8 patients across 7 studies and had an effect size of 0.23 (CI: -0.13, 0.59). The collagen crosslink dataset included 44 patients across 2 studies and had an effect size of 0.37 (CI: 0.09, 0.65). The fibril diameter dataset included 168 patients across 11 studies and had an effect size -0.13 (CI: -0.24, 0.02). The melting temperature dataset is expressed as absolute mean difference, it included 85 patients across 26 studies and had an effect size of -2.29 (CI: -3.32, -1.35). These findings show the collagen pathway is altered in OI, beyond the initial mutation. Our study provides new insights into collagen-I pathophysiology in OI, generating new hypotheses regarding the collagen pathway and mediating disease presentation in different tissues and overall severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.